The U.S. Food and Drug Administration has urged to withdraw Sanofi's heartburn drug Ranitidine as well as its generics from the market with immediate effect for possible contamination. The recall involves all prescription and over-the-counter or OTC ranitidine drugs, commonly known by the brand name Zantac. The recall includes generic products that contain ranitidine made by Novartis, Endo...
from RTT - Biotech https://ift.tt/2xG1R7F
via IFTTT
No comments:
Post a Comment